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Abstract 
Background: The introduction of patient screens for outpatient procedures is 
becoming increasingly common.   To date the impact on the patient of viewing the 
screen remains unknown.  Objectives: To explore how viewing the screen during a 
hysteroscopy procedure affects the patient’s experience.  Setting: The outpatient 
clinics at the Royal Surrey Hospital in Guildford and the Royal Infirmary in Bradford.  
Design:  A randomised control trial.  Sample: Women undergoing a hysteroscopy 
procedure were randomly allocated to see the screen (n=81) or not to see the screen 
(n=76).  Results: Seeing the screen or not had no impact on several measures of pain 
perception, mood, illness cognitions or communication.  However, patients who did 
not see the screen were more optimistic about the effectiveness of their treatment and 
felt that the health professional was more receptive to them during the consultation 
compared to those who saw the screen.   After controlling for the use of a local 
anaesthetic, those who did not see the screen also reported a greater decrease in 
anxiety after the procedure.  However, those who saw the screen described pain more 
positively (i.e. in terms of comfort, reassurance or encouragement) compared to those 
who did not see the screen.   Conclusion:  Viewing the screen does not benefit 
patients and may interfere with the patient - physician interaction. 
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Introduction 
A hysteroscopy is most often prescribed following uterine problems such as bleeding 
or pain and can either be diagnostic or operative (1).  A hysteroscopy can be carried 
out under a general anaesthetic although most are now carried out using a local or 
regional anaesthetic within the context of ‘one stop’ and ‘see and treat’ out patient 
clinics (2).    Research has explored women’s experiences of undergoing a 
hysteroscopy in these contexts and suggest that the although procedure is associated 
with raised anxiety and pain most patients state that they would still rather have the 
procedure in an outpatient clinic under the same conditions than be admitted into 
hospital (3-8).  
 
Contemporary gynaecological procedures including hysteroscopy use modern 
technology such as telescopes and monitors which allow clinicians to have a more 
precise understanding of what changes are occurring in a patients’ health (9).   Many 
clinics now also enable the patient to see the procedure either on their own screen or 
the clinician’s screen.   Although such visual imaging has proved to be beneficial for 
the clinician as a means to carry out such procedures, there remains only limited 
evidence concerning the potential impact of seeing the procedure on the patient 
experience.   For example, Sutton (10) provides a review of the hysteroscopy 
procedure and suggests that some patients find viewing the screen during the 
procedure an interesting and informative experience, although some can find it 
unnerving.   Morgan et al (11) carried out a small scale descriptive study to explore 
women’s experiences of having a hysteroscopy which included a reference to the 
impact of seeing the screen.   They analysed the data from 29 women and concluded 
that whilst 10 women had watched the screen as they were interested in the procedure 
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and found it a distraction from their pain, 14 had chosen to look away for fear of 
becoming anxious through what they might see.   Morgan et al (11) also described 
how those who did not see the screen reported more pain.    A further 5 were unable to 
see the screen as it was positioned out of their line of sight.    
 
This study therefore suggests that viewing a procedure on a screen may influence a 
number of different aspects of the patient’s experience.  First, the results indicate a 
role for pain perception which is in line with research indicating that an individual’s 
attentional state through focus or distraction can exacerbate or minimise the pain they 
experience (12,13).   Second the results indicate that seeing the screen may influence 
an individual’s mood, particularly their level of anxiety which finds reflection in 
research illustrating how information about a medical procedure can either increase or 
decrease negative mood (eg. 14, 15).    Third, Morgan et al (11) also highlighted the 
importance of communication and the patient’s relationship with the clinician 
although the impact of the screen on this variable was not examined.   It is possible 
that having a screen available for both the clinician and patient could change the 
communication between these two individuals.   Research in Primary Care indicates 
that the increasing use of computers within the General Practice consultation has 
implications for the doctor patient relationship (16,17).   In line with this, the 
availability of the screen during a hysteroscopy may also have an impact upon the 
communication process although whether the presence of a screen is either positive or 
negative remains unclear.   
 
Patients are therefore increasingly being given access to a screen in order to watch 
their hysteroscopy procedure.   The impact of this remains unknown although 
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preliminary exploratory research suggests that the screen may have an impact upon 
the patient experience in terms of pain perception, mood and communication.   The 
present study therefore aimed to test these findings quantitatively using an 
experimental design with patients being randomly allocated to seeing or not seeing the 
screen during their procedure.   Research within parallel areas also indicates a role for 
illness cognitions which are the ways in which a person makes sense of their health 
problem.   In particular, Leventhal and colleagues (eg. 18) argue that people make 
sense of their health problem in terms of a number of different dimensions such as 
beliefs about the cause of their problem and beliefs about the impact of the problem 
on their lives and much research indicates that these dimensions are consistently held 
by patients with a range of illnesses including coronary heart disease, diabetes, 
obesity and cancer (19,20).   Furthermore, research also indicates that they can change 
following information, education, side effects of medication and symptom experience 
(21,22).   It is possible that seeing a hysteroscopy procedure on a screen could change 
the ways in which a patient makes sense of their health problem.   Accordingly the 
present study also explored the impact of viewing the screen on patients’ illness 
cognitions. 
 
Method  
Design 
The study involved a randomised trial with two conditions: seeing the screen versus 
not seeing the screen.   Baseline mood and clinical variables were measured before 
the procedure.  Aspects of the patients’ experience (mood, pain perception, illness 
cognitions, communication with the health professional) were assessed after the 
procedure.    
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Participants 
Consecutive patients attending the hysteroscopy outpatient clinics at the Royal Surrey 
County Hospital in Guildford and the Bradford Royal Infirmary were invited to take 
part in the study.   Patients were excluded if they did not speak sufficient English to 
complete the questionnaire (or did not have someone with them who could translate) 
or if they ended up not having a hysteroscopy.   Women who did not wish to be 
randomised were also excluded from the study.   Approximately 60 were approached 
in Bradford and 132 were approached in Surrey (these numbers are approximate due 
to some data not being recorded).  Completed questionnaires were received from 117 
patients from the Royal Surrey and 40 from Bradford.   Data collection took place in 
two blocks with the Bradford component occurring in 2006 and the Royal Surrey 
occurring in 2007.  The project was approved by the Bradford and Royal Surrey Local 
Research Ethics Committees.  Due to this being the first trial in this area and the 
absence of any existing data on the impact of seeing the screen during a hysteroscopy 
no formal sample size calculation was carried out.   However, it was calculated that 
with alpha set at 5% and beta set at 80% a sample size of 150 (n=75 in each arm) 
should be sufficient to detect a medium effect size. 
 
Procedure  
On the day of appointment all patients attending the hysteroscopy clinic were invited 
to take part in the research. Those who agreed were further informed about the 
purpose of the study and provided with the information sheet and consent form.  The 
patients were advised that fifty percent of women would see the screen during the 
procedure and fifty percent would not see the screen depending on the number on the 
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questionnaire. Patients who agreed to continue signed the consent form and completed 
the baseline questionnaire. The follow up questionnaire was completed by patients 
after the hysteroscopy had been carried out.  The questionnaire was anonymous and 
not linked to the patient’s notes. 
 
Randomisation 
Randomisation was carried out using a random number generator.  An odd number on 
the questionnaire meant that the patient was not able to see the screen during the 
procedure, and an even number indicated that the person was able to see the screen 
during the procedure.  All participants were asked to pick the top questionnaire from a 
randomly ordered pile.  
 
Measures 
Baseline 
The baseline questionnaire consisted of the following: 
i) Demographics: Participants described their age, occupation, ethnicity, whether they 
were a parent (excluding fostering and adoption), method of delivery (“vaginal”, 
“caesarean” or “both”) and first language.  
 
ii) Mood (Pre Hysteroscopy): Participants completed an adapted version of the Profile 
of Mood States questionnaire (POMS; 23) to describe their mood in terms of anxiety 
(8 items), depression (14 items), fatigue (4 items) and vigour (6 items) rated on a 5 
point Likert scales ranging from ‘Not at all’ (1) to ‘Very much’ (5).   
 
Follow up 
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The follow up questionnaire consisted of the following: 
i) Mood (Post Hysteroscopy): The POMS questionnaire was completed for a second 
time.  Changes scores for each mood subscale were computed (follow up – baseline) 
for the analysis. 
 
ii) Pain perception: Perceived pain was assessed using an adapted version of the 
McGill Pain Questionnaire (24) to evaluate two aspects of pain: sensory (eg. 
flickering, quivering, pulsing (6 items)) and affective (eg. punishing, gruelling (5 
items)).  In addition, positive pain items (eg. interesting, reassuring, comfortable (4 
items)) and negative pain items (eg. painful, frightening, worrying (4 items)) were 
added to the scale and checked for internal reliability.  Patients rated these constructs 
on a 5 point Likert scale ranging from “not at all” (1) to “extremely” (5).   All items 
has Cronbach’s alphas >0.6). 
 
iii) Illness cognitions:  These were assessed using an adapted version of the Illness 
Perception Questionnaire (IPQR; 25, 26) to assess different dimensions of illness 
cognitions each of which was rated using three items: cause of problem (e.g. ‘stress or 
worry’; ‘My own behaviour’; ‘hereditary – it runs in the family’), its consequences 
(e.g. “my problem has major consequences on my life”), time line (e.g. “my problem 
will last a short time”), treatment effectiveness (eg. ‘my treatment can control my 
problem’), affect (e.g. “my problem is a misery to me”) and sense making (e.g. “my 
problem is puzzling to me”).  Patients rated dimensions of the IPQ on a 5 point Likert 
type scale ranging from “strongly disagree” (1) to “strongly agree” (5).   The causal 
items were summated to create a variable reflecting psychological causes (eg. ‘My 
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own behaviour’) and one reflecting a belief in biological causes (eg. ‘hereditary – it 
runs in the family’). 
 
iv) Communication:  The interaction with the health professional was assessed using 
a measure of patient centeredness developed by Ogden et al (27). This focuses on four 
dimensions of the interaction with the health professional each of which is assessed 
using 3 items: patient involvement (eg. “my clinician allowed me to speak freely”), 
emotional interaction (eg. “my clinician was aware of my feelings in the 
consultation”), information giving (eg. “my clinician explained the possible 
consequences of my problem”) and doctor receptiveness (eg. “I felt my doctor 
acknowledged my views when discussing the cause of my problem”).   Each item was 
rated on a 5 point Likert scale ranging from ‘Not at all’ (1) to ‘Very much’ (5). 
 
vi) Clinical variables:  Patients were also asked if this was their first experience of 
having a hysteroscopy and if not they were asked to indicate how many previous 
hysteroscopies they had had and to describe the gender of the health professional who 
had carried out their current procedure.  The researcher noted what type of 
hysteroscopy they had (“diagnostic”, “operative” or “coil”), and the qualification of a 
health professional that carried out the procedure (nurse vs doctor vs consultant).   In 
addition, whether or not they had been administered a local anaesthetic during the 
procedure was recorded for 116 patients.   The missing data for this variable was due 
to a change in researcher and could not be obtained after the patient had left the clinic 
as the data collection process was anonymous. 
 
Data analysis 
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The data were analysed to describe the participants’ demographic and clinical 
variables and to explore differences in these variables between the two conditions 
using either t tests (for scale data) or X2 for (dichotomous data).   The data were then 
analysed to assess the impact of the intervention (screen on vs screen off) on aspects 
of the patient’s experience (change in mood, pain perception, illness cognitions and 
communication with the health professional) using ANOVA.   Finally, this analysis 
was repeated using the presence or absence of a local anaesthetic as a covariate using 
ANCOVA.  Partial eta2 is reported for the analyses of the impact of the intervention 
as a measure of effect size. 
  
Results 
1. Participants’ demographic and clinical variables 
Participants’ demographic and clinical variables and differences in these factors by 
condition are shown in table 1. 
-Insert table 1 about here - 
The sample consisted of 157 women aged between 21 and 74.  The majority of 
patients were white whose first language was English.  The majority of women had 
children, with the most common type of delivery being vaginal delivery followed by 
caesarean delivery.  Most had not had a hysteroscopy before although a number of 
women reported that they have had one hysteroscopy in the past and a minority of 
patients reported having two or three previous hysteroscopies. The majority of women 
underwent the hysteroscopy for diagnosis and did not receive a local anaesthetic.  Of 
the 157 women undergoing a hysteroscopy procedure 81 had the screen on whilst 76 
had the screen off.   
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The results showed that the two conditions were comparable for all demographic and 
clinical variables. 
 
2. Impact of the intervention on patient outcomes.  
The data were analysed to assess the impact of the intervention (screen on vs screen 
off) on aspects of the patient’s experience (change in mood, illness cognitions, pain 
perception, communication with the health professional) using one-way ANOVA.  
 
i) Mood 
Differences in changes in mood from baseline to follow up by condition are shown in 
Table 2. 
-insert table 2 about here- 
The results showed no impact of the intervention on patients’ change in mood.   
 
ii) Pain perception 
Differences in pain perception by condition are shown in Table 3. 
-insert table 3 about here - 
The results showed no significant impact of the intervention on patients’ perception of 
pain.  
 
iii) Illness cognitions 
Differences in illness cognitions by condition are shown in table 4. 
-insert table 4 about here- 
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The results showed no impact of the intervention on patients’ beliefs about the cause, 
consequences, meaning or time line of their problem.   However, those who had the 
screen on reported feeling less optimistic about the effectiveness of their treatment. 
 
iv) Communication with the health professional 
Differences in perceptions of communication with the health professional are shown 
in table 5. 
-insert table 5 about here - 
The results showed that the intervention had no impact upon patients’ experiences of 
communication with the health professional in terms of patient involvement, affect 
and information giving.  However those who did not see the screen felt that the health 
professional was more receptive to them during the consultation.  
 
4. Impact of the intervention (controlling for the use of a local anaesthetic).   
Due to the potential impact of receiving a local anaesthetic on the patient experience 
the above analysis was repeated using local anaesthetic as a covariate in those 
participants for whom this was assessed (n=116: screen on n=51; screen off n=54).  In 
line with the analysis described above, the results showed that those patients who did 
not see the screen during the procedure were more optimistic about the effectiveness 
of the treatment they were offered (F[104,1]=6.93, eta2 =0.06, p=0.01) and felt that 
the health professional was more receptive to them during the consultation 
(F[104,1]=3.83, eta2 =0.04, p=0.05).  In contrast to the above results however, those 
who saw the screen described pain in more positive terms (eg. comfort, reassurance, 
interesting) (F[104,1]=6.09, eta2 =0.06, p=0.02) but showed a smaller decrease in 
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their anxiety levels than those who did not see the screen (F[104,1]=5.09, eta2 =0.05, 
p=0.03). 
 
Discussion 
The present study aimed to assess the impact of viewing the screen during a 
hysteroscopy on the patient’s experience. 
 
The results showed that whether the patients saw the screen or not had no impact 
upon their pain perception which is in contrast to the suggestion made by Morgan et 
al (11).   Further it does not support research which indicates that distraction and or 
focus can ameliorate the pain experience (12, 13).   The results also showed no impact 
of seeing the screen on changes in mood, several aspects of illness cognitions and the 
patient’s experience of communication with the health professional.   However, the 
results indicated that having the screen off resulted in the patient’s reporting greater 
confidence in the effectiveness of their treatment and describing improved 
communication with the health professional in terms of the clinician’s receptiveness 
to their views.   Furthermore, when controlling for the use of a local anaesthetic the 
results also showed that those not seeing the screen reported a greater decrease in 
anxiety compared to before the procedure.    These results support previous studies 
indicating that illness cognitions can be changed by information (eg. 22), that the 
presence of a screen may be detrimental for communication (16,17) and that seeing a 
procedure may exacerbate anxiety (11).  The results from the present study, however, 
indicate that the impact of the screen was not entirely negative with patients who saw 
the screen being more likely to use terms such as ‘interesting’ and ‘reassuring’. 
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To conclude, although the use of patient screens is becomingly common practice for a 
number of outpatient procedures these results indicate that it may not be a benign 
intervention and may have a number of implications for the patient experience.    In 
the main the results indicate that having a screen on whilst having a hysteroscopy has 
a negative impact in terms of mood, cognitions and communication with the health 
professional.   These results not only have implications for the use of screens for 
patients undergoing a hysteroscopy but also for the increasing number of other out 
patient based procedures where screens are being introduced.  Further research is 
needed to support the results from the present study both in the context of having a 
hysteroscopy and also for other similar procedures.   In addition, how patients from 
different cultures, social classes and with different patient histories differentially 
experience viewing a screen could also be examined. 
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Table 1: Differences in demographics and clinical variables by condition.  
 
Variable 
 
N Screen on 
(n=81) 
Screen off 
(n=76) 
T or X² P 
Location of the 
hospital 
157 Guildford= 62 
Bradford= 19 
Guildford = 55 
Bradford= 21 
X² = 0.36 p= 0.55 
Age (yrs) 119 Mean = 45.5 
SD = 12.61 
Mean = 47.7 
SD = 10.76 
t = -1.04 p = 0.30 
Ethnicity 132 White = 64 
Asian = 2 
Other = 0 
White = 62 
Asian = 3 
Other = 1 
X² = 1.23 P= 0.54 
First Language 
 
132 English =  65 
Other = 1 
English = 62 
Other = 4 
X² = 1.87 P= 0.17 
Children?  120 No = 11 
Yes = 47 
No = 11 
Yes = 51 
X² = 0.03 P= 0.86 
Type of 
delivery 
118 Vaginal = 36 
Caesarean = 7 
Both = 3 
No children =11 
Vaginal = 39 
Caesarean = 4 
Both = 7 
No children = 11 
X² = 2.40 P= 0.49 
No. of  
hysteroscopies 
154 None = 62 
One = 13 
Two = 3 
None = 55 
One = 17 
Two = 1 
X² = 2.18 P = 0.54 
Procedure 
 
157 Diagnostic = 78 
Operative = 0 
Coil = 3 
Diagnostic = 70 
Operative = 4 
Coil = 2 
X² = 4.48 p = 0.11 
Qualification of 
health 
professional 
117 Nurse = 7 
Doctor = 17 
Consultant = 38 
Nurse = 6 
Doctor = 16 
Consultant = 33 
X² = 0.04 p = 0.98 
Gender of a 
health 
professional 
157 Male = 39 
Female = 39 
Both = 3 
Male = 35 
Female = 39 
Both = 2 
X² =0.26 p = 0.88 
Local 
anaesthetic 
116 No = 45 
Yes = 10 
No = 47 
Yes = 14 
X² = 0.40 p = 0.52 
Occupation  110 Housewife = 11 
Employed = 44 
Unemployed= 0 
Retired = 3 
Housewife = 8 
Employed = 35 
Unemployed  = 3 
Retired = 6 
X² = 5.19 p = 0.16 
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Table 2: Impact of intervention on mood at follow up 
 
Variable Screen on 
(n=81) 
Screen of 
(n=75) 
F P Partial 
eta 
squared 
Change in 
Anxiety  
Mean = -
0.18 
SD = 0.68 
 
Mean = -
0.39 
SD = 0.76 
3.24 0.07 0.03 
Change in 
Depression  
Mean = -
.0.09 
SD = 0.41 
 
Mean = -
0.08 
SD = 0.41 
0.001 0.98 0.0001 
Change in 
Vigour  
 
Mean = -
0.19 
SD = 0.70 
Mean = -
0.12 
SD = 0.70 
0.41 0.52 0.0001 
Change in 
Fatigue  
 
Mean = 0.14 
SD = 0.83 
Mean = 0.10 
SD = 0.70 
0.09 0.77 0.001 
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Table 3: Impact of intervention on pain perception 
 
Variable Screen on 
(n=81) 
Screen off 
(n=75) 
F P Partial 
eta 
squared 
 
Sensory 
pain 
Mean = 1.61 
SD = 0.70 
 
Mean = 1.63 
SD = 0.73 
0.35 0.85 0.0001 
Affective 
pain 
Mean = 1.30 
SD = 0.69 
 
Mean = 1.36  
SD = 0.69 
0.32 0.57 0.003 
Negative 
pain 
 
Mean = 2.19  
SD = 0.92 
Mean = 2.35 
SD = 1.00 
1.03 0.31 0.01 
Positive pain Mean = 2.81 
SD = 0.91 
Mean = 2.55 
SD = 0.75 
3.63 0.06 0.05 
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Table 4: Impact of the intervention on illness cognitions 
Variable 
 
Screen on 
(n=81) 
Screen off 
(n=75) 
F P Partial 
eta 
squared 
Consequences 
of illness 
Mean = 2.46 
SD = 0.85 
 
Mean = 2.55 
SD = 0.76 
0.50 0.48 0.003 
Treatment 
effectiveness 
 
Mean = 3.50 
SD = 0.80 
Mean = 3.77 
SD = 0.59 
5.44 0.02* 0.04 
Sense making Mean = 2.23 
SD = 0.90 
Mean = 2.22 
SD = 0.85 
0.01 0.97 0.0001 
Biological 
cause  
 
Mean = 2.02 
SD = 0.80 
Mean = 2.05 
SD = 0.68 
0.04 0.83 0.001 
Psychological 
cause 
 
Mean = 1.92 
SD = 0.83  
Mean = 2.00 
SD = 0.74 
0.35 0.56 0.0001 
Time-line of 
illness 
 
Mean = 2.61 
SD = 0.89 
Mean = 2.60 
SD = 0.74 
0.01 0.92 0.0001 
 
*significant impact of intervention 
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Table 5: Impact of the intervention on communication with the health 
professional.   
 
Variable Screen on 
(n=81) 
Screen off 
(n=75) 
F P Partial 
eta 
squared 
Patient’s 
Involvement 
Mean = 
3.61 
SD = 0.68 
 
Mean = 
3.68 
SD = 0.66  
0.39 0.53 0.003 
Emotional 
Interaction 
Mean = 
4.29 
SD = 0.59 
 
Mean = 
4.27 
SD = 0.64 
0.05 0.83 0.002 
Information 
giving 
Mean = 
3.98 
SD = 0.80 
 
Mean = 
3.82 
SD = 0.74 
1.51 0.22 0.02 
Doctor’s 
Receptiveness 
Mean = 
3.94 
SD = 0.65 
 
Mean = 
4.16 
SD = 0.68 
4.12 0.04* 0.03 
 
* significant impact of the intervention 
